RRM2 and lung adenocarcinoma: In lung adenocarcinoma (LUAD), the overexpression of RRM2 was an independent predictive factor of poor prognosis, which increased the activation of Bcl-2 and E-cadherin signaling pathways and reduced the activation of the p53 signaling pathway (Jin et al., 2020).